Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

757 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Current strategies for the treatment of CLL.
Montserrat E, Hallek M. Montserrat E, et al. Among authors: hallek m. Leuk Lymphoma. 1996 Oct;22 Suppl 2:65-8. doi: 10.3109/10428199609102704. Leuk Lymphoma. 1996. PMID: 9021710 Review. No abstract available.
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.
Feuring-Buske M, Kneba M, Unterhalt M, Engert A, Gramatzki M, Hiller E, Trümper L, Brugger W, Ostermann H, Atzpodien J, Hallek M, Aulitzky E, Hiddemann W. Feuring-Buske M, et al. Among authors: hallek m. Ann Hematol. 2000 Sep;79(9):493-500. doi: 10.1007/s002770000163. Ann Hematol. 2000. PMID: 11043420 Clinical Trial.
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia.
Huhn D, von Schilling C, Wilhelm M, Ho AD, Hallek M, Kuse R, Knauf W, Riedel U, Hinke A, Srock S, Serke S, Peschel C, Emmerich B; German Chronic Lymphocytic Leukemia Study Group. Huhn D, et al. Among authors: hallek m. Blood. 2001 Sep 1;98(5):1326-31. doi: 10.1182/blood.v98.5.1326. Blood. 2001. PMID: 11520778 Free article. Clinical Trial.
757 results